One novel ellagic acid derivative, desglauside (1), was isolated from the leaves of Desbordesia glaucescens together with three known compounds [3ˈ,4ˈ-di-Omethylellagic acid (2), oleanolic acid (3) and β-sitosterol-3-O-β-D-glucopyranoside (4)]. Their structures were elucidated on the basis of NMR spectroscopic and MS analysis, and by comparison with related published data. The crude extract, fractions and isolated compounds showed no activity against four yeast strains [Candida albicans (ATCC 9002), C. parapsilopsis (ATCC22019), C. tropicalis (ATCC750), Cryptococcus neoformans (IP95026) and one isolate of Candida guilliermondii].
Desbordesia glaucescens (Engl.) Tiegh. (Irvingiaceae) is a large tree attaining 50 m in height and is found around forest zones in South Nigeria, West Cameroon, Gabon, Congo, and Angola [1] . In Congo, the seeds are used as a food additive while bark-decoctions are taken to attenuate stomach-ache, and as an aphrodisiac [2] . Ointments made with barks and palm-oil are used to treat chickenpox and headache [3] . No phytochemical study has been carried out on D. glaucescens, although several investigations on other species of this family revealed the presence of ellagic acid derivatives and triterpenes [4a] . In our continuing search of bioactive secondary metabolites from Cameroonian medicinal plants [4b, 5a] , we report herein the isolation, structural characterization, and antifungal activities of a new ellagic acid derivative (1) and three known compounds (2) (3) (4) .
The ethanol extract of the leaves of D. glaucescens was partitioned successively with n-hexane and ethyl acetate, as indicated in the experimental section. The residual fraction was subjected to repeated column chromatography over silica gel and Sephadex LH-20 to afford desglauside (1), along with three known compounds: 3ˈ,4ˈ-di-O-methylellagic acid (2) [5b], oleanolic acid (3) [5c] and βsitosterol-3-O-β-D-glucopyranoside (4) [5d]. The known compounds were identified by comparison of their spectroscopic data with those reported in the literature.
Desglauside (1) was obtained as a white powder and its FT-ESI-MS had a pseudo-molecular ion peak [M+H] + at m/z = 493.09799 corresponding to the molecular formula C 22 H 20 O 13 and consistent with 13 double-bond equivalents. The IR spectrum showed characteristic absorption bands of a hydroxyl group (3460 cm −1 ), lactone functions (1745 cm −1 ), aromatic C=C groups (1615 cm -1 ) and a glycosidic C-O bond (1085 cm −1 ) [6a] . Additional to the quasi-molecular ion peak (at m/z = 493 [M+H] + ), the low resolution ESIMS of 1 exhibited characteristic ion peaks at m/z = 331 [M+H-162] + , and 236 [M-162-CO 2 -OMe-H 3 O + ] + , indicative of the presence of glucosyl, carbonyl, methoxyl and hydroxyl groups in its structure. The UV spectrum displayed absorption maxima at λ max 250 and 362 nm similar to those of other ellagic acid derivatives [6a,b] . The 13 C NMR spectrum of 1 (Table 1 ) exhibited a total of 22 1: R = Glu, 2: R = H carbon atoms including seven methines (two aromatic and five oxygenated carbons), one oxymethylene, twelve quaternary aromatic carbons, [two carbonyls of α, β-unsaturated lactone groups at δ 158.8 (C-7 and C-7ˈ)] [6b], and two methoxyl carbons at δ 61.7 (3ˈ-OMe) and 57.1 (4ˈ-OMe).
The 1 H NMR spectrum of 1 (Table 1) (δ 141.0) of 1 were respectively compared with those of C-4 (δ 147.1) and C-3 (δ 140.7) for stachyanthuside A [6e]. This was strengthened by HMBC correlations (Table 1) observed between the proton at δ 7.64 (H-5ˈ) and carbons at δ 112.8 (C-1ˈ), 140.1 (C-3ˈ), and 154.5 (C-4ˈ); and between the proton at δ 7.78 (H-5) and carbons at δ 147.5 (C-4) and 114.2 (C-6), respectively. Further HMBC correlations observed between the proton at δ 4.03 and the carbon at δ 140.1; and between the proton at δ 4.00 and the carbon at δ 154.5 were evidence that these two methoxyl groups were located at positions C-3ˈ, and C-4ˈ, respectively.
Apart from additional signals due to a methoxyl group in 1 corresponding to 4ˈ-OMe, all the spectroscopic data were similar to those of stachyanthuside A, previously reported from leaves of Diplopanax stachyanthus [6e]. The structure of the novel compound was therefore assigned as 3ˈ,4ˈ-di-O-methylellagic acid 4-O-β-Dglucopyranoside (1), to which a trivial name desglauside was given.
The crude extract, fractions and isolated compounds showed no activity against four yeast strains [Candida albicans (ATCC 9002), C. parapsilopsis (ATCC22019), C. tropicalis (ATCC750), Cryptococcus neoformans (IP95026) and one isolate of Candida guilliermondii] (data not shown). It is noteworthy that no previous study has investigated the pharmacological activity of D. glaucescens. The absence of antifungal activity of the extract and fractions is reported here for the first time.
Experimental
General: Melting points, Electrothermal IA9000 series digital melting point apparatus; IR, Shimadzu FTIR-8400S spectrophotometer; MS, Thermo Scientific LTQ-Orbitrap instrument coupled to a MALDI or by HPLC coupled to Waters Quattro instrument; NMR, Bruker AVANCE DMX 400. CC, Merck silica gel 60 (0.063-0.200 mm) and on Sephadex LH-20; TLC silica gel GF 254 pre-coated plates with detection accomplished by visualizing with a UV lamp at 254 and 365 nm, followed by spraying with 50% H 2 SO 4 and then heating to 100°C.
Plant material:
The leaves of Desbordesia glaucescens were collected in Suza (Littoral region-Cameroon) in March 2012. The plant material was authenticated (voucher number 53939/HNC) at the National Herbarium in Yaoundé by a botanist (Mr Mezili Paul).
Extraction and isolation:
Air-dried and powdered leaves (4 Kg) of D. glaucescens were extracted with EtOH (10 L) at room temperature for 48 h and filtered. The filtrate was concentrated to dryness under vacuum to give 205 g of crude extract (CE). The obtained extract was suspended in distilled water and subjected to a liquid-liquid extraction using n-hexane and EtOAc to give n-hexane (HF), ethyl acetate (EAF), and residual (RF) fractions, respectively. In the preliminary bioassay, fractions HF and EAF were not as active as RF against Candida tropicalis and were not further investigated.
Part of the residual fraction (90 g) was subjected to CC over silica gel and eluted with a gradient of CH 2 Cl 2 -EtOAc and EtOAc-MeOH of increasing polarity. Fifty fractions of 300 mL each were collected and combined into 4 major fractions (F1-F4) based on their TLC profiling. Fraction F1 (3,5 g) was further separated using CC over silica gel, with CH 2 Cl 2 -EtOAc gradients to afford 3 (10 mg), while separation of fraction F2 (3,9 g) with an EtOAc-MeOH mixture of increasing polarity yielded 3-O-β-D-glucopyranoside (4) (20 mg). Finally fraction F4 (40 g) was also subjected to CC over silica gel and eluted with an isocratic solvent system [CH 2 Cl 2 -EtOAc-MeOH (3:2:0.5)] to give 1 (10 mg) and 2 (25 mg).
Desglauside (1) (14) 
Acid hydrolysis of compound 1:
A solution of 4 mg of 1 in 10 mL MeOH mixed with 5 mL HCl (2N) was refluxed at 100°C for 3 h. After evaporation of the organic solvent in vacuo and extraction of the aqueous phase with EtOAc the aglycone (2) was identified by TLC. The aqueous residue was concentrated to dryness by adding MeOH to remove acid and D-glucose was identified by comparative TLC with a standard sample.
